Kyverna Therapeutics, Inc. (KYTX) — Operating Cash Flow
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$153.71M | -34.5% |
| 2024 | -$114.25M | -118.0% |
| 2023 | -$52.41M | — |
| Fiscal Year | Operating Cash Flow | Change YoY |
|---|---|---|
| 2025 | -$153.71M | -34.5% |
| 2024 | -$114.25M | -118.0% |
| 2023 | -$52.41M | — |